Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge - Wikidata - thesis-toulmin - TriplyDB

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge

http://www.wikidata.org/entity/Q34081625

about

Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs Biocompatibility of chitosan carriers with application in drug delivery.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.Strategies for intranasal delivery of vaccines Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.Evaluation of the efficacy of chitosan nanoparticles loaded ΦKAZ14 bacteriophage in the biological control of colibacillosis in chickens.Prenatal nicotine exposure enhances the susceptibility to metabolic syndrome in adult offspring rats fed high-fat diet via alteration of HPA axis-associated neuroendocrine metabolic programming.Mucosal vaccine delivery: Current state and a pediatric perspective Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.Recent developments in nanocarrier-aided mucosal vaccination.Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.A Review of DNA Vaccines Against Influenza

P2860

Q28080092-F1C946A6-4915-4261-951C-EC05D5E80F79 Q33649839-AA9E7581-A0D0-42F8-B367-F3322E74E6D4 Q34309830-147EC3A2-BA06-4543-B0E4-4DF54254D2F7 Q34661842-F95E1809-8F6B-4EF4-852C-7E70DF57B28A Q35858585-AEBC2D10-995D-4BAC-9EC7-9915F1532720 Q36066573-5CC65AD4-E87E-4620-A96C-38438284AB5F Q36514771-69D6DCF2-B468-4886-85C0-625C4632CF0B Q36745790-9E414541-01E4-48BA-B230-1CE6668844E6 Q37606227-67A22C9D-E874-4C08-AB8D-080016826466 Q37728447-E428B3D1-542E-496C-BD6A-C54CC972B169 Q38727453-3C3CB843-1594-45D6-9DB4-D9A9959562C3 Q38827869-AB8CC22A-E679-476B-B61C-AC6BE0E91EA1 Q38862465-062AD373-2B9A-4930-B6BB-F49F686FDFD9 Q40228907-A3A79E7D-855D-4BE8-AA5F-D8F314F0119B Q40482585-9E506BB5-751A-4118-A774-1B2980A043CF Q47137438-93F8E2FF-4B49-4E89-978A-254B10E4B810 Q53127398-6CF84C7C-0967-4099-9CA2-3E19B4C8431F Q57094261-AC036999-2512-41E7-8205-5D5AAC518A12

P2860

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge

http://www.wikidata.org/entity/Q34081625

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@ast

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@en

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@nl

type

label

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@ast

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@en

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@nl

prefLabel

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@ast

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@en

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@nl

P1433

Q34081625-83172B2F-073C-4799-842B-BE3F56AAC673

P1476

Q34081625-C8CCBCF9-0141-45DC-B8FE-37D8C3F8BB02

P2093

Q34081625-075E113F-D2F2-42AA-A4AE-849A32A10F99

Q34081625-280EED12-AE61-463C-9F95-61A5866CEFD7

Q34081625-42EB21FF-A0F7-4055-9EB9-632C94B2B94B

Q34081625-4F1A0A45-D6D3-43F4-B03A-A820092C5AF4

Q34081625-66C36B9C-C9A9-464A-876E-D8D76B8A9F11

Q34081625-6809AA1B-21AD-468A-AF28-3295632B525E

Q34081625-8B15EB9C-8DBA-40C4-B167-87BCA6159CBD

Q34081625-8C4A1856-9C55-46B3-B8CC-CC4FBA9A1608

Q34081625-FAB2425E-7C9A-4D25-B576-A3FEDDA5ADB9

P2860

Q34081625-04EBA3B6-BB63-44AE-8055-79B904734C13

Q34081625-17EF83B1-8874-4957-B250-ACDB51F3C1E9

Q34081625-1CBE5A23-C5C7-470E-A0B2-2035680B537C

Q34081625-209855A6-0587-43E1-A949-E21980B87B8C

Q34081625-2CD7B81D-529B-48E2-962C-9410C5FB68FD

Q34081625-3378F438-E29F-47E8-8A6A-E0E543FCEA7B

Q34081625-37D5CE62-C506-46D0-B787-CAC56DE16009

Q34081625-3D319C43-AECB-49ED-8DAA-2C1AFA8F4AD8

Q34081625-40609308-AF34-434D-866F-4C2E9D67C16D

Q34081625-69D57F08-49B4-4959-B567-AF67EA61C413

P304

Q34081625-15FF583D-214E-4F93-83BB-5AA22FC11F15

P31

Q34081625-AA7CDCA4-8306-45DE-A873-79DB6A0F03C4

P356

Q34081625-4BC8ADE7-990B-42A3-AA5F-BBD0B3CEFD15

P407

Q34081625-A5BEE61D-76DC-47C9-A0F0-73D8FF2152B3

P433

Q34081625-D3FBD425-51B8-4C5E-9968-F32386F39457

P478

Q34081625-3AFCC0F2-BFE0-40A6-B7E4-DA817049AD3B

P577

Q34081625-D41E1BE5-3F34-4032-BE56-A4E320DCB2FC

P5875

Q34081625-CAEA1D7D-B7DF-4A9C-9A72-04805943652C

P698

Q34081625-8A1EAE70-BB3A-4FEA-8F9F-730FC680E062

P932

Q34081625-42E9BA69-612A-477C-9889-5CD8C55E716F

P356

JOURNAL.PONE.0027605

P1433

P1476

Intranasal delivery of cationi ...... mmunity against FMDV challenge

@en

P2093

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Jianliang Lü

http://www.w3.org/2001/XMLSchema#string

Li Pan

http://www.w3.org/2001/XMLSchema#string

Peng Zhou

http://www.w3.org/2001/XMLSchema#string

Shoutian Jiang

http://www.w3.org/2001/XMLSchema#string

Yongguang Zhang

http://www.w3.org/2001/XMLSchema#string

Yonglu Wang

http://www.w3.org/2001/XMLSchema#string

Yuzhen Fang

http://www.w3.org/2001/XMLSchema#string

Zhongwang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Respiratory mucosal immunization with reovirus serotype 1/L stimulates virus-specific humoral and cellular immune responses, including double-positive (CD4(+)/CD8(+)) T cells.

Vaccination strategies for mucosal immune responses

Trojan particles: large porous carriers of nanoparticles for drug delivery.

Polysaccharide colloidal particles as delivery systems for macromolecules.

Chitosans for gene delivery.

Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro.

Nanoparticle and targeted systems for cancer therapy.

Developments in foot-and-mouth disease vaccines.

Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs

Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine.

P304

e27605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0027605

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51824225

http://www.w3.org/2001/XMLSchema#string

P698

22110686

http://www.w3.org/2001/XMLSchema#string

P932

3216981

http://www.w3.org/2001/XMLSchema#string